FDA Adverse Event Injury Summary report: N

XPERT SELF-EXPANDING TRANSHEPATIC STENT SYSTEM

MDR report key: 3923024 · Received July 9, 2014

Report

Report Number
2024168-2014-04419
Event Type
Injury
Date Received
July 9, 2014
Date of Event
June 30, 2013
Report Date
May 23, 2014
Manufacturer
AV-TEMECULA-CT
Product Code
FGE
PMA / PMN Number
K050534
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AR, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE REPORTED PATIENT EFFECT OF THROMBOSIS IS A KNOWN OBSERVED AND POTENTIAL PATIENT EFFECT AS LISTED IN THE XPERT INSTRUCTION FOR USE (IFU). ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING. DATE OF EVENT ESTIMATED. DATE OF IMPLANT ESTIMATED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A SIGNIFICANT FOCAL LESION LOCATED IN THE LEFT SUPERFICIAL FEMORAL ARTERY. A FIBROCALCIFIC PLAQUE WAS VISUALISED AT THE LESION SITE. OPTICAL COHERENCE TOMOGRAPHY (OCT) IMAGING AND PRE-DILATATION OF THE LESION WAS PERFORMED PRIOR TO STENTING WITH AND XPERT STENT. POST-DILATATION WAS PERFORMED WITH GOOD RESULTS. REPEAT OCT IMAGING SHOWED COMPLETE EXPANSION OF THE STENT WITH OPTIMAL WALL APPOSITION. A SMALL RESIDUAL THROMBUS (MICROTHROMBUS) ON THE STENT SURFACE WAS VISUALIZED. THE PATIENT WAS TREATED WITH DUAL-ANTIPLATELET THERAPY FOR 1 MONTH WITH SIGNIFICANT IMPROVEMENT IN HER SYMPTOMS DURING FOLLOW-UP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
399992 XPERT SELF-EXPANDING TRANSHEPATIC STENT SYSTEM SELF-EXPANDING STENT AND DELIVERY SYSTEM FGE AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention SHEATH: 6 FR CROSSOVER